Abstract—
The experimental study of the cardioprotective effect of uridine, the metabolic precursor of the endogenous activator of mitochondrial ATP-dependent K+-channels (mitoKATP-channels), was performed using the model of myocardial ischemia/reperfusion injury (I/RP) in rats. Ischemia for 30 min followed by reperfusion for 120 min resulted in a significant decrease in the ATP and phosphocreatine (PCr) content, intensification of lipid peroxidation (LPO), and inhibition of the antioxidant system (AOS) in cardiomyocytes. Intravenous administration of uridine (30 mg/kg) had a protective effect on the myocardial metabolism in the zone of I/RP. It prevented the I/RP-induced decrease of ATP and PCr, limited LPO processes, evaluated by the content of lipid hydroperoxides (LHP) and conjugated dienes (CD), and improved the AOS state by, preventing a decrease of superoxide dismutase (SOD) activity and increasing the content of reduced glutathione (GSH). The intravenous injection of mitoKATP-channel blocker 5-hydroxydecanoate (5-HD, 5 mg/kg, 5 min before uridine) eliminated the ability of uridine to maintain the ATP level and to exhibit its positive effect on the intensity of the LPO and activity of AOS. The data obtained suggest that the activation of mitoKATP-channels plays an important role in the mechanism of the cardioprotective effect of uridine in the myocardial I/RP.
Similar content being viewed by others
REFERENCES
Boytsov, S.A., Samorodskaya, I.V., Nikulina, N.N., Yakushin, S.S., Andreyev, E.M., and Zaratiants, O.V., Ter. Arkhiv, 2017, vol. 89, no. 9, pp. 53−59. https://doi.org/10.17116/terarkh201789953-59
Yellon, D.M. and Hausenloy, D.J., N. Engl. J. Med., 2007, vol. 357, pp. 1121−1135. https://doi.org/10.1056/NEJMra071667
Hashmi, S. and Al-Salam, S., Int. J. Clin. Exp. Pathol., 2015, vol. 8, pp. 8786−8796.
Heusch, G. and Gersh, B., Eur. Heart J., 2017, vol. 38, pp. 774−764. https://doi.org/10.1093/eurheartj/ehw224
Tavares, J.G.P., Errate, P.R., and Govate, T.C.P., Acta Cir. Bras., 2018, vol. 33, pp. 588−596. https://doi.org/10.1590/s0102-865020180070000004
Testai, L., Rapposelli, S., Martelly, A., and Breschi, M.C., Med. Res. Rev., 2015, vol. 35, pp. 520−553. https://doi.org/10.1002/med.21332
Mironova, G.D., Skarga, Yu.Yu., Grigoriev, S.M., Negoda, A.E., Kolomytkin, O.V., and Marinov, B.S., J. Bioenerg. Biomembr., 1999, vol. 31, pp. 157−161.
Mironova, G.D, Negoda, A.E., Marinov, B.S., Paucek, P., Costa, A.D.T., Grigoriev, S.M., Skarga, Yu.Yu., and Garlid, K.D., J. Biol. Chem., 2004, vol. 279, pp. 32562−32568. https://doi.org/10.1074/jbc.M401115200
Matsushita, S. and Fanburg, B., Circ. Res., 1970, vol. 27, pp. 415−428.
Eliseev, V.V., Rodionova, O.M., Sapronov, N.S., and Selizarova, N.O., Pat. Fiziol. Exper. Ter., 2002, no. 2, pp. 13−15.
Sapronov, N.S., Eliseev, V.V., and Rodionova, O.M., Bull. Exp. Biol. Med., 2000, vol. 130, pp. 411−414.
Bul’on, V.V., Krylova, I.B., and Selina, E.N., Obzory Klin. Farmakol. Lekarstv. Ter., 2018, vol. 16, pp. 13−17. https://doi.org/10.17816/RCF16213-17
Lishmanov, Y.B., Naryzhnaya, N.V., Tsibulnikov, S.Y., Wang, H., and Maslov, L.N., Bull. Exp. Biol. Med., 2017, vol. 163, pp. 22−24. https://doi.org/10.1007/s10517-017-3728-8
Fryer, R.M., Eells, J.T., Hsu, A.K., Henry, M.M., and Gross, G.J., Am. J. Physiol. Heart Circ. Physiol., 2000, vol. 278, pp. H305−H312. https://doi.org/10.1152/ajpheart.2000.278.1.H305
Lee, T.-M., Su, Sh.-F., Tsai, Ch.-Ch., Lee, Y.-T., and Tsai, Ch.-H., J. Mol. Cell Cardiol., 2000, vol. 32, pp. 1147−1158. https://doi.org/10.1006/jmcc.2000.1167
Gamper, N.L., Saar, V.G., Koroleva, E.M., and Savina, N.V., J. Evol. Biochem. Physiol., 1998, vol. 34, pp. 178−182.
Arutyunyan, A.V., Dubinina, E.E., and Zybina, N.N., Metody otsenki svobodnoradikal’nogo okisleniya i antioksidantnoi sistemy organizma: metodicheskie rekomendatsii (Methods for Assessing Free Radical Oxidation and the Antioxidant System of the Body: Guidelines), Khavinson, V.Kh., Ed., Saint Petersburg: Foliant, 2000.
Bul’on, V.V., Krylova, I.B., Selina, E.N., Emelyanova, L.V., Mironova, G.D., and Sapronov N.S., Meditsinkyi Akadem. Zh., 2010, vol. 10, pp. 89−94.
Belosludtseva, N.V., Krylova, I.B., Bulion, V.V., Selina, E.N., Rodionova, O.M., Sapronov, N.S., and Mironova, G.D., in Mitokhondrial’nye pory, kanaly i ustojchivost’ kletok k povrezhdayushchim vozdeistviyam (Mitochondrial Pores, Channels, and Cell Resistance to Damaging Effects), Akatov V.S. and Lemasters, J.J., Eds., Pushchino: SynchroBook, 2016, pp. 49−71.
Vanden Hoek, T.L., Becker, L.B., Shao, Z., Li, C., and Schumacker, P.T., Circ. Res., 2000, vol. 86, pp. 541−548. https://doi.org/10.1161/01.res.86.5.541
Al-Salam, S. and Hashmi, S., Cell. Physiol. Biochem., 2018, vol. 50, pp. 1123−1139. https://doi.org/10.1159/000494539
Annapurna, A., Mudagal, M.P., Ansari, A., and Rao, S., Exp. Clin. Cardiol., 2012, vol. 17, pp. 110−114.
Mozaffari, M., Liu, J.Y., Abebe, W., and Baban, B., Am. J. Cardiovasc. Dis., 2013, vol. 3, pp. 180−196.
Rodrigo, R., Libuy, M., Feliu, F., and Hasson, D., Biomed. Res. Int., 2013, vol. 35, pp. 773−790. https://doi.org/10.1155/2013/974358
European Convention for the protection of vertebrate animals used for experimental and other scientific purposes, European Treaty Series No. 123, Strasburg, 1986.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The experimental work was performed in accordance with the provisions of the European Convention for the Protection of Vertebrate Animals used for experimental and other scientific purposes [25] and was approved by the IEM Ethics Committee.
The authors declare that they have no conflict of interest.
Additional information
Translated by A. Medvedev
Abbreviations used: ADav—mean arterial pressure; AOS—antioxidant system; CD—conjugated dienes; GSH—reduced glutathione; 5-HD—5-hydroxydecanoate; HPLC—high performance liquid chromatography; HR—heart rate; I/RP—ischemia/reperfusion injury; LCA—left coronary artery; LHP—lipid hydroperoxides; LPO—lipid peroxidation; mitoKATP channels—mitochondrial ATP dependent K+ channels; PCr—phosphocreatine; ROS—reactive oxygen species; SOD—superoxide dismutase; UDP—uridine diphosphate.
Rights and permissions
About this article
Cite this article
Bul’on, V.V., Selina, E.N. & Krylova, I.B. The Protective Effect of Uridine on Metabolic Processes in the Rat Myocardum during its Ischemia/Reperfusion Injury. Biochem. Moscow Suppl. Ser. B 14, 33–37 (2020). https://doi.org/10.1134/S1990750820010072
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750820010072